Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wakamoto Intestinal Regulators
- Development stage
- Unknown
- Lead developer
- Wakamoto
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Wakamoto Intestinal Regulators (also known as Wakamoto Intestinal Remedy) is a designated quasi-drug probiotic formulation developed by Wakamoto Pharmaceutical. It is designed to regulate the digestive system and improve intestinal health. The formulation contains three types of live lactic acid bacteria: two strains of bifidobacteria (*Bifidobacterium longum* and *Bifidobacterium bifidum*) that primarily act in the large intestine, and *Lactobacillus gasseri* (formerly classified as *Lactobacillus acidophilus*) which works mainly in the small intestine. Together, these beneficial bacteria inhibit the proliferation of harmful intestinal flora, balance the gut microbiome, and alleviate gastrointestinal symptoms such as constipation, loose stools, and abdominal bloating.
- Brand names
- Wakamoto Intestinal RegulatorsWakamoto Intestinal Remedy
- Other names
- Wakamoto Intestinal Regulating MedicineWakamoto Intestinal Remedy GranulesWakamoto Intestinal Remedy Tabletsわかもと整腸薬
Beyond the preview
Go deeper on Wakamoto Intestinal Regulators.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wakamoto Intestinal Regulators.